Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α-Reference-Cited by-同舟云学术

Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α

Published:2022-01 Issue: Volume:288 Page:120171
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Nayeem Md Junayed,Yamamura Aya,Hayashi Hisaki,Muramatsu Hiroyuki,Nakamura Kogenta,Sassa Naoto,Sato Motohiko

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Androgens and prostate cancer; pathogenesis and deprivation therapy;Grossmann;Best Pract. Res. Clin. Endocrinol. Metab.,2013

3. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches;Karantanos;Oncogene,2013

4. Nerve growth factor induces proliferation and aggressiveness in prostate cancer cells;Di Donato;Cancers,2019

5. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer;Zhao;Sci. Transl. Med.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy;MedComm;2023-09-14

2. CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy;Frontiers in Cell and Developmental Biology;2022-01-11